Omeros | OMER - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Adma Biologics USD 75.76M 2.22M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Immunic USD 38.36M 7.74M 2026-03
Insmed USD 438.74M 77.74M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 122.01M 13.22M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06